Fig. 2

Clinical outcomes of 144 LSCC patients and expression of 7 target proteins. Kaplan-Meier analyses of overall survival (OS) and disease-free survival (DFS) were performed for 144 patients classified into high- and low-expression groups of STXBP4, TP63 (ΔNp63), p53, VEGFR2, TUBB3, STMN1, and PD-; X axis, survival time expressed in months